Exeter Financial, LLC’s Abbvie Inc Position
Does Exeter Financial, LLC own Abbvie Inc (ABBV)? Yes — 21.5K shares worth $5M (+1.91% of its 13F portfolio) as of Q1 2026, up from 20.4K shares the prior filed quarter.
Position Value
$5M
Q1 2026
Shares
21.5K
% of Portfolio
+1.91%
Quarters Held
30
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 21.5K | $5M | +1.91% |
| Q4 2025 | 20.4K | $5M | +1.98% |
| Q3 2025 | 20.1K | $5M | +2.01% |
| Q2 2025 | 19.7K | $4M | +1.63% |
| Q1 2025 | 19.8K | $4M | +1.86% |
| Q4 2024 | 19.7K | $3M | +1.60% |
| Q3 2024 | 19.6K | $4M | +1.72% |
| Q2 2024 | 20.8K | $4M | +1.70% |
| Q1 2024 | 21.8K | $4M | +1.69% |
| Q4 2023 | 22.0K | $4M | +1.73% |
| Q3 2023 | 21.7K | $3M | +1.71% |
| Q2 2023 | 21.1K | $3M | +1.48% |
| Q1 2023 | 20.6K | $3M | +1.67% |
| Q4 2022 | 20.9K | $3M | +1.76% |
| Q3 2022 | 21.0K | $3M | +1.64% |
| Q2 2022 | 20.4K | $3M | +1.74% |
| Q1 2022 | 20.5K | $3M | +1.80% |
| Q4 2021 | 21.8K | $3M | +1.63% |
| Q3 2021 | 22.1K | $2M | +1.42% |
| Q2 2021 | 22.0K | $3M | +1.47% |
| Q1 2021 | 22.0K | $2M | +1.50% |
| Q4 2020 | 21.3K | $2M | +1.58% |
| Q3 2020 | 21.3K | $2M | +1.46% |
| Q2 2020 | 21.3K | $2M | +1.74% |
| Q1 2020 | 22.2K | $2M | +1.59% |
| Q4 2019 | 21.1K | $2M | +1.45% |
| Q3 2019 | 21.4K | $2M | +1.29% |
| Q2 2019 | 21.4K | $2M | +1.30% |
| Q1 2019 | 20.8K | $2M | +1.45% |
| Q4 2018 | 21.4K | $2M | +1.86% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Exeter Financial, LLC’s full portfolio or all institutional holders of ABBV.